Google, YouTube, Facebook, Twitter all these platforms are unabashedly censoring anything that is alternative to the "official narrative". That should tell you which masters these serve.
What they actually want is for the people to think as little as possible for themselves, accept any narrative they sell, and remain engrossed in their games and other entertainment avenues like zombies while the world around them is changed to suit the whims of a select few.
Welcome to BitChute, a peer-to-peer content sharing platform and associated services. BitChute aims to put creators first and provide them with a service that they can use to flourish and express their ideas freely.
These Community Guidelines give an overview of the behaviour that is expected from you and the rest of the BitChute community. By continuing to use the site, you are agreeing with and accepting these Community Guidelines in their entirety. They should be read and understood in conjunction with Our Commitment to the BitChute community.
Why is the U.S. allowing vaccines for those who are pregnant, but the U.K. isn’t? Because the vaccines have not yet been tested in those who are pregnant, the U.K. has opted to wait for more data before recommending vaccinations for that group.
In the U.S., regulators decided to give people in this group the option to get the vaccine if they choose.
Much more information in the link, but this paragraph demonstrates the fact that there are different opinions, risks, testing procedures in different parts of the world.
Covid: Israel vaccine fears 'out of context and inaccurate' By Rachel Schraer
Israel, one of the top countries when it comes to vaccinating against Covid-19, bought large stocks of the jab in exchange for acting as the world's guinea pig.
And scientists are watching data shared by the country keenly, for signs of how effective the vaccine is when given to a whole population.
So there was understandable concern when the man coordinating Israel's Covid response reportedly suggested a single dose of the Pfizer vaccine might not be as effective as reported.
Thousands of people have tested positive after being jabbed. But are worries premature?
Addressing Prof Nachman Ash's quotes, the Israeli Ministry of Health said: "The comments of the Israeli Covid-19 commissioner regarding the effect of the first dose of the vaccine was out of context and, therefore, inaccurate. (So they need a disclaimer too)
"The commissioner said we have yet to see a decrease in the number of severely ill patients.
"As the second dose is now given to the most vulnerable of the population, we expect to soon see the full protective impact of the vaccine".
After vaccination, the body needs time to recognise the virus's genetic material and mount an immune response - producing the antibodies and T-cells that block the virus from entering cells and killing off those cells that do become infected.
And it takes over two weeks to really take effect, immunologists, including Prof Danny Altmann at Imperial College London, say .
'Early protection' Clalit, Israel's largest healthcare provider, covering most of the population, compared the medical records of 200,000 vaccinated over-60s with the same number belonging to unvaccinated people.
For two weeks after the first dose, both groups tested positive for the virus at roughly the same rate.
But then, those vaccinated started to show 33% fewer new infections than the others.
"This is very early protection," Clalit chief innovation officer, Ran Balicher, who is also a public health professor advising the government, said.
And "already there is a 33% fall".
Infections continued to decline after that.
But there were too few for Prof Balicher to calculate by what percentage.
Same trend The London School of Hygiene and Tropical Medicine's Prof Stephen Evans said: "It is not sensible to compare efficacy derived from an observational study of this type, which is subject to many biases, with the efficacy derived from randomised trials [such as those performed to test the vaccine in the first place]."
But the early evidence does follow roughly the same trend seen in Pfizer's clinical trials, which involved tens of thousands of people.
In those trials, the rate of new infections in the vaccinated and control groups also diverged after two weeks.
And that gap kept widening for more than 100 days after the first dose.
Severe Covid Israel began vaccinating on 19 December, reaching 10% of its population by the end of 2020.
And now, about half a million of its nine million population have received two doses.
Given the time it takes for immunity to build and unvaccinated people to become exposed to the virus, incubate it and develop symptoms, the national data would not be expected to reflect the impact of vaccination for at least a month.
But Prof Balicher suggests some impact on severe Covid illness across Israel could be expected to be seen later this week.
Less effective Pfizer hopes two doses of the vaccine will give up to 95% protection.
But even a much less effective vaccine could make the difference between a survivable illness and a fatal one.
The annual flu vaccine is about 40-60% effective.
And it stops hundreds of thousands of people from dying every year.
Fatal disease "Efficacy against detected Covid-19 may be less important... than efficacy against hospitalisation and death," Prof Evans said.
And more people were likely to be protected from a severity of illness requiring admission to hospital than infection rates alone suggested.
The Clalit data, for example, does not distinguish between mild or symptomless infections and more severe or even fatal disease.
The judgement made in the UK was more lives could be saved by giving a larger group one dose quicker than giving a smaller group the maximum protection conferred by two doses.
And Prof Evans said: "The reports that have come from Israel are insufficient to provide any evidence that the current UK policy in regard to delaying the second dose of vaccines is in any way incorrect."
CDC reports rare allergic reactions to Moderna’s Covid-19 vaccine
The Moderna Covid-19 vaccine, like the one made by Pfizer and BioNTech, appears to induce rare anaphylactic reactions in a small number of people who receive the vaccine, new data from the Centers for Disease Control and Prevention suggest.
As of Jan. 19, there have been 15 confirmed cases of anaphylaxis after receipt of Moderna’s vaccine and 45 confirmed cases of anaphylaxis after receipt of the Pfizer vaccine, the CDC said in a statement to STAT. That works out to a rate of 2.1 cases per million doses of the Moderna vaccine and 6.2 cases per million doses of the Pfizer, according to the agency.
Anaphylaxis is a severe allergic reaction that can be life-threatening if not treated quickly.
“Early monitoring of both the Moderna and the Pfizer-BioNTech Covid-19 vaccines indicate that anaphylaxis following vaccination is a rare event, and although anaphylaxis is serious, it occurs shortly after vaccination (usually within minutes), is readily diagnosed, and effective treatments are available,” the agency said via email.
This cannot be undone and I am sure it will be greatly appreciated.
We apologise but you have been denied access to report posts in this thread. This could be due to excessively reporting posts and not understanding our forum rules. For assistance or information, please use the forum help thread to request more information. Jazakallah